Cargando…

Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection

OBJECTIVE: Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, was first identified in December 2019 in Wuhan, China, and has since spread globally, resulting in an ongoing pandemic. However, the study of asymptomatic patients is still rare, and the understanding of its...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wei, Chen, Xinmiao, Xu, Xiaoting, Leng, Zhefeng, Yu, Wenwen, Lin, Hui, Li, Huiying, Lin, Jie, Qiu, Zhangwei, Dai, Yuanrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504765/
https://www.ncbi.nlm.nih.gov/pubmed/33005276
http://dx.doi.org/10.1155/2020/2045341
_version_ 1783584699172519936
author Dai, Wei
Chen, Xinmiao
Xu, Xiaoting
Leng, Zhefeng
Yu, Wenwen
Lin, Hui
Li, Huiying
Lin, Jie
Qiu, Zhangwei
Dai, Yuanrong
author_facet Dai, Wei
Chen, Xinmiao
Xu, Xiaoting
Leng, Zhefeng
Yu, Wenwen
Lin, Hui
Li, Huiying
Lin, Jie
Qiu, Zhangwei
Dai, Yuanrong
author_sort Dai, Wei
collection PubMed
description OBJECTIVE: Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, was first identified in December 2019 in Wuhan, China, and has since spread globally, resulting in an ongoing pandemic. However, the study of asymptomatic patients is still rare, and the understanding of its potential transmission risk is still insufficient. In this study, epidemiological investigations were conducted in the Zhejiang province to understand the epidemiology and clinical characteristics of asymptomatic patients with COVID-19. METHODS: This retrospective study was carried out on 22 asymptomatic patients and 234 symptomatic patients with COVID-19 who were hospitalized in Zhejiang Duodi Hospital from January 21 to March 16, 2020. The characteristics of epidemiology, demography, clinical manifestations, and laboratory data of mild patients were compared and analyzed. RESULTS: The median age was 28 years in asymptomatic patients and 48 years in symptomatic patients. The proportion who were female was 77.3% in asymptomatic patients and 36.3% in symptomatic patients (p < 0.001). The proportion of patients with coexisting diseases was 4.5% in asymptomatic patients and 38.0% in symptomatic patients (p=0.002). The proportion of patients with increased CRP was 13.6% in the asymptomatic group and 61.1% in the symptomatic group (p < 0.001). The proportion of patients received antiviral therapy was 45.5% in the asymptomatic group and 97.9% in the symptomatic group (p < 0.001). The proportion of patients received oxygen therapy was 22.7% in the asymptomatic group and 99.1% in symptomatic patients (p < 0.001). By March 16, 2020, all patients were discharged from the hospital, and no symptoms had appeared in the asymptomatic patients during hospitalization. The median course of infection to discharge was 21.5 days in asymptomatic patients and 22 days in symptomatic patients. CONCLUSIONS: Asymptomatic patients are also infectious; relying only on clinical symptoms, blood cell tests, and radiology examination will lead to misdiagnosis of most patients, leading to the spread of the virus. Investigation of medical history is the best strategy for screening asymptomatic patients, especially young people, women, and people without coexisting disease, who are more likely to be asymptomatic when infected. Although the prognosis is good, isolation is critical for asymptomatic patients, and it is important not to end isolation early before a nucleic acid test turns negative.
format Online
Article
Text
id pubmed-7504765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75047652020-09-30 Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection Dai, Wei Chen, Xinmiao Xu, Xiaoting Leng, Zhefeng Yu, Wenwen Lin, Hui Li, Huiying Lin, Jie Qiu, Zhangwei Dai, Yuanrong Can Respir J Research Article OBJECTIVE: Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, was first identified in December 2019 in Wuhan, China, and has since spread globally, resulting in an ongoing pandemic. However, the study of asymptomatic patients is still rare, and the understanding of its potential transmission risk is still insufficient. In this study, epidemiological investigations were conducted in the Zhejiang province to understand the epidemiology and clinical characteristics of asymptomatic patients with COVID-19. METHODS: This retrospective study was carried out on 22 asymptomatic patients and 234 symptomatic patients with COVID-19 who were hospitalized in Zhejiang Duodi Hospital from January 21 to March 16, 2020. The characteristics of epidemiology, demography, clinical manifestations, and laboratory data of mild patients were compared and analyzed. RESULTS: The median age was 28 years in asymptomatic patients and 48 years in symptomatic patients. The proportion who were female was 77.3% in asymptomatic patients and 36.3% in symptomatic patients (p < 0.001). The proportion of patients with coexisting diseases was 4.5% in asymptomatic patients and 38.0% in symptomatic patients (p=0.002). The proportion of patients with increased CRP was 13.6% in the asymptomatic group and 61.1% in the symptomatic group (p < 0.001). The proportion of patients received antiviral therapy was 45.5% in the asymptomatic group and 97.9% in the symptomatic group (p < 0.001). The proportion of patients received oxygen therapy was 22.7% in the asymptomatic group and 99.1% in symptomatic patients (p < 0.001). By March 16, 2020, all patients were discharged from the hospital, and no symptoms had appeared in the asymptomatic patients during hospitalization. The median course of infection to discharge was 21.5 days in asymptomatic patients and 22 days in symptomatic patients. CONCLUSIONS: Asymptomatic patients are also infectious; relying only on clinical symptoms, blood cell tests, and radiology examination will lead to misdiagnosis of most patients, leading to the spread of the virus. Investigation of medical history is the best strategy for screening asymptomatic patients, especially young people, women, and people without coexisting disease, who are more likely to be asymptomatic when infected. Although the prognosis is good, isolation is critical for asymptomatic patients, and it is important not to end isolation early before a nucleic acid test turns negative. Hindawi 2020-09-19 /pmc/articles/PMC7504765/ /pubmed/33005276 http://dx.doi.org/10.1155/2020/2045341 Text en Copyright © 2020 Wei Dai et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dai, Wei
Chen, Xinmiao
Xu, Xiaoting
Leng, Zhefeng
Yu, Wenwen
Lin, Hui
Li, Huiying
Lin, Jie
Qiu, Zhangwei
Dai, Yuanrong
Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title_full Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title_fullStr Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title_full_unstemmed Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title_short Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection
title_sort clinical characteristics of asymptomatic patients with sars-cov-2 in zhejiang: an imperceptible source of infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504765/
https://www.ncbi.nlm.nih.gov/pubmed/33005276
http://dx.doi.org/10.1155/2020/2045341
work_keys_str_mv AT daiwei clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT chenxinmiao clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT xuxiaoting clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT lengzhefeng clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT yuwenwen clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT linhui clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT lihuiying clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT linjie clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT qiuzhangwei clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection
AT daiyuanrong clinicalcharacteristicsofasymptomaticpatientswithsarscov2inzhejianganimperceptiblesourceofinfection